Kuros Biosciences (XSWX:KURN) Additional Paid-In Capital : CHF73.32 Mil(As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Kuros Biosciences Additional Paid-In Capital?

Kuros Biosciences's quarterly additional paid-in capital stayed the same from Dec. 2022 (CHF160.16 Mil) to Jun. 2023 (CHF160.16 Mil) and stayed the same from Jun. 2023 (CHF160.16 Mil) to Dec. 2023 (CHF73.32 Mil).

Kuros Biosciences's annual additional paid-in capital increased from Dec. 2021 (CHF154.59 Mil) to Dec. 2022 (CHF160.16 Mil) but then declined from Dec. 2022 (CHF160.16 Mil) to Dec. 2023 (CHF73.32 Mil).

Kuros Biosciences Additional Paid-In Capital Historical Data

The historical data trend for Kuros Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Additional Paid-In Capital Chart

Kuros Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

118.16

125.06

154.59

160.16

73.32

Kuros Biosciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															154.59	154.59	160.16	160.16	73.32

Kuros Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Kuros Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences (XSWX:KURN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (XSWX:KURN) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

CSBTF:USA KURNz:UK

Address

Wagistrasse 25, Schlieren, Zurich, CHE, 8952

Website

https://www.kurosbio.com

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences (XSWX:KURN) Headlines

No Headlines